A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
The purpose of the study is to characterize the immunogenicity & safety of 2 doses of GSK's avian flu vaccine GSK 1557484A given according to different regimens to adults aged 18 to 64 years
| Main Author: | |
|---|---|
| Format: | Dataset |
| Language: | unknown |
| Published: |
Vivli
2018
|
| Subjects: | |
| Online Access: | https://dx.doi.org/10.25934/00000648 https://search.vivli.org/doiLanding/studies/00000648/isLanding |
| Summary: | The purpose of the study is to characterize the immunogenicity & safety of 2 doses of GSK's avian flu vaccine GSK 1557484A given according to different regimens to adults aged 18 to 64 years |
|---|